Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1999
03/24/1999CN1211926A Pharmaceutical composition for immunomodulation based on peptides and adjuvants
03/24/1999CN1211923A Ligands to enhance cellular uptake of biomolecules
03/24/1999CN1211917A Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
03/24/1999CN1211578A PEG-inerferon conjugates
03/24/1999CN1211450A Improving stability of prostaglandin medicine
03/23/1999US5886168 Low D.E. starch conversion products having a sharp differentiation in molecular size
03/23/1999US5886143 Reagent including at least nine hexose residues connected in iteratively branched configuration, functional moiety capable of reacting with binding moiety, target moiety or active agent
03/23/1999US5886048 PHMB for the treatment of tumor disease
03/23/1999US5886042 Amphoteric compostion and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/23/1999US5886041 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/23/1999US5886038 Topically administering to a human a composition having isopropyl myristate as the only active ingredient
03/23/1999US5886030 Use of vitamin E tocopheryl derivatives in ophthalmic compositions
03/23/1999US5886026 Anti-angiogenic compositions and methods of use
03/23/1999US5886018 Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
03/23/1999US5885978 External therapeutic composition for dermatitis
03/23/1999US5885960 Method of treatment comprising administering a combination comprising FGF and polyelectrolytes
03/23/1999US5885618 Compressible enzyme powder
03/23/1999US5885615 Enzyme resist, sustained release pills comprising high viscosity adjuvant
03/23/1999US5885613 Lipid, polyethyleneglycol-ceramide conjugate reversibly associated with said lipid to stabilize said lipid in a bilayer structure; drug delivery
03/23/1999US5885596 Methods and compositions for fine lines and/or wrinkles
03/23/1999US5885594 Enhancing the organoleptic characteristics of fattiness, soothing, creaminess, and full mouthfeel by adding an acylglycerol compound comprising atleast two long chain conjugated polyunsaturated fatty acids to food and beverages
03/23/1999US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine
03/23/1999US5885591 Personal lubricant compositions
03/23/1999US5885570 Induction of tolerance with modified immunogens
03/23/1999US5885565 Methods for inducing phase separation of epithelial lipid bilayers
03/23/1999US5885557 Topical mixture of 1,3-dihydroxyacetone, a penetration attenuator and a carrier; rapid ?sloughing off? of the induced tan from the affected areas; psoriasis; eczema
03/23/1999US5885491 Adding monosaccharide cryoprotective agent into an aqueous dispersion of a nanocapsules while maintaining gentle stirring until same dissolves, freezing the dispersion and dehydrating by heating to obtain stable lyophilized product
03/23/1999CA2052713C Delivery of agents
03/23/1999CA2051439C Liposomal targeting of ischemic tissue
03/18/1999WO1999013329A1 Methods of identifying molecules that home to angiogenic vasculature in tumors
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013056A1 IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs)
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012875A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012572A1 Compounds and method for the prevention and treatment of diabetic retinopathy
03/18/1999WO1999012570A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
03/18/1999WO1999012568A1 Stabilizers containing recombinant human serum albumin for live virus vaccines
03/18/1999WO1999012565A1 Vaccines
03/18/1999WO1999012549A2 Controlled release microsphere delivery system
03/18/1999WO1999012545A2 Medicaments containing acyclovir
03/18/1999WO1999012544A1 Intranasal formulation containing scopolamine and method of treating motion sickness
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012520A1 Compositions adapted for prolonged residence in the nasal pharynx
03/18/1999WO1999012416A1 T-independent conjugate-vaccines
03/18/1999WO1998058629A3 Preparation of pharmaceutical compositions
03/18/1999WO1998055531A3 Process for the preparation of copolyesters
03/18/1999WO1998052614A3 Composition and method for enhancing transport across biological membranes
03/18/1999CA2303444A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
03/18/1999CA2303443A1 Compositions adapted for prolonged residence in the nasal pharynx
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2302762A1 Controlled release microsphere delivery system
03/18/1999CA2302637A1 Vaccine compositions comprising an oil/water emulsion with saponin and sterol
03/18/1999CA2302282A1 Stabilizers containing recombinant human serum albumin for live virus vaccines
03/17/1999EP0902090A1 Compound capable of introducing at least one molecule into a cell.
03/17/1999EP0901811A2 Mixtures of long chain alkyl esters of orthophosphoric acids
03/17/1999EP0901792A1 Agent for peroral administration, its production and use
03/17/1999EP0901786A2 Solid pharmaceutical dispersions with enhanced bioavailability
03/17/1999EP0901502A1 Lytic peptides
03/17/1999EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901377A1 Acne treatment
03/17/1999EP0901371A1 Alteration of microbial populations in the gastrointestinal tract
03/17/1999EP0901368A1 Dermal penetration enhancers and drug delivery systems involving same
03/17/1999EP0831858A4 Intrauterine chemical necrosing method and composition
03/17/1999EP0736045B1 Use of mono-3,6-anhydro-cyclodextrins for solubilising a hydrophobic compound and monitoring the purity of an enantiomer, and method for preparing said cyclodextrins
03/17/1999EP0618806B1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
03/17/1999EP0593562B1 Topical composition containing penciclovir
03/17/1999CN1211278A Conjugation of polypeptides
03/17/1999CN1211191A Gel formulations containing growth factors
03/17/1999CN1211189A Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
03/17/1999CN1211185A Sulfate conjugates of ursodeoxychloric acid, and their beneficial use in inflammatory disorders and other applications
03/17/1999CN1211166A Liquid oral compositions comprising a calcium compound and an acidulant
03/17/1999CA2247767A1 A novel composition for controlled and sustained transdermal administration
03/17/1999CA2247764A1 Bifunctional water-soluble polymer derivative and complex containing it
03/16/1999US5883135 Composition, device, and method for enhanced electrotransport agent delivery
03/16/1999US5883128 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/16/1999US5883103 Oral acyclovir delivery
03/16/1999US5883088 Gallium complexes of 3-hydroxy-4-pyrones provide enhanced gallium bioavailability
03/16/1999US5883078 Hemostyptic and tissue adhesive
03/16/1999US5882941 Programmable genotoxic agents and uses therefor
03/16/1999US5882713 Starches, jet cooking, dispersion in water, solubilized starch and recovering an emulsion
03/16/1999US5882676 Skin permeation enhancer compositions using acyl lactylates
03/16/1999US5882675 Percutaneous absorption preparation
03/16/1999US5882663 Topical pain-relieving preparation containing C12 To C18 isoparaffins
03/16/1999US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and
03/16/1999US5882654 Polyvalent melanoma vaccine
03/16/1999US5882645 Peptide compounds
03/16/1999US5882639 Topically treating photodermatitis, thermal burn, decubitus ulcer, or herpes zoster
03/16/1999US5882626 Therapy for killing tumor cells using antibodies
03/16/1999US5882330 Drugs and methods for treating diseases
03/16/1999CA2172373C Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
03/16/1999CA2168248C Antifungal nail solution
03/16/1999CA2167570C Flavanolignan preparations with improved liberation and resorbability
03/16/1999CA2155763C Cosmetic compositions
03/16/1999CA2103447C Use of nano particles as pharmaceutical carriers
03/16/1999CA1340437C Interleukin 2 receptor and applications thereof
03/11/1999WO1999011809A1 Conjugates that contain the homeodomain of antennapedia
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
1 ... 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 ... 1712